This research builds on the ground - breaking
cell reprogramming work of their Gladstone colleague, Shinya Yamanaka, MD, PhD.
Not exact matches
In 2005, before a Congressional hearing in the U.S., Prof. George Q. Daley of Harvard spoke forcefully and influentially about the necessity for embryonic stem -
cell research to go ahead, and dismissed suggestions that one could
work instead with «induced pluripotent stem
cells» («iPS», i.e. stem
cells reprogrammed from some
cells of a living adult).
Work with skin
cells reprogrammed to mimic embryos had suggested the mutation would be repaired in fewer than 30 percent of
cells.
The research team from the Department of Biochemistry and Molecular Biology headed by Professor Susanne Mandrup are publishing a paper entitled «Browning of human adipocytes requires KLF11 and
reprogramming of PPAR super-enhancers» in the January 1 edition of the scientific journal Genes & Development that describes their results from
working with «brite» fat
cells.
But like the medieval alchemists, today's cloning and stem
cell biologists are
working largely with processes they don't fully understand: What actually happens inside the oocyte to
reprogram the nucleus is still a mystery, and scientists have a lot to learn before they can direct a
cell's differentiation as smoothly as nature's program of development does every time fertilized egg gives rise to the multiple
cell types that make up a live baby.
Working with human breast cancer
cells and mouse models of breast cancer, scientists identified a new protein that plays a key role in
reprogramming cancer
cells to migrate and invade other organs.
Researchers might generate personalized brain organoids from the
reprogrammed skin
cells of individuals with, say, schizophrenia and test which medications
work best for patients with particular genetic profiles of the illness.
Researchers are also
working to develop a trial where they will
reprogram CAR T
cells to identify the CD19 and CD22 proteins simultaneously, enabling them to target the cancer
cells from more than one angle with the initial round of T -
cell immunotherapy.
As many as a dozen major labs, he says, have since tried but failed to make
reprogramming work in human
cells.
«
Cell reprogramming is revolutionising medicine, yet surprisingly little is known about how it actually works,» says stem cell expert Vincent Pasque, assistant professor at KU Leuven, Belg
Cell reprogramming is revolutionising medicine, yet surprisingly little is known about how it actually
works,» says stem
cell expert Vincent Pasque, assistant professor at KU Leuven, Belg
cell expert Vincent Pasque, assistant professor at KU Leuven, Belgium.
As a result, many of the studies published up to now describe only two or three patient stem
cell lines,» says David Panchision, who oversees the NIMH's National Cooperative Reprogrammed Cell Research Group (NCRCRG) program, which supported this w
cell lines,» says David Panchision, who oversees the NIMH's National Cooperative
Reprogrammed Cell Research Group (NCRCRG) program, which supported this w
Cell Research Group (NCRCRG) program, which supported this
work.
In recent years, Muotri and colleagues have created in vitro cellular models of autism using
reprogrammed induced pluripotent stem
cells (iPSC) derived from discarded baby teeth of children with autism,
work dubbed the «tooth fairy project.»
The award was given for their
work showing that mature
cells can be
reprogrammed into pluripotent stem
cells.
But Hochedlinger, whose group's paper appears in a new journal called
Cell Stem
Cell, stresses that researchers still need to study human
cells to learn how to
reprogram them and have no idea yet which approach would
work better in the long run.
Previous
work suggested they were as malleable as embryonic stem
cells and so could be
reprogrammed to make any kind of tissue.
Earlier
work has shown that grafted stem
cells reprogrammed to become neurons can, in fact, form new, functional circuits across an injury site, with the treated animals experiencing some restored ability to move affected limbs.
At the same time, the
work provides new clues for successfully
reprogramming cells in humans and advances in regenerative medicine and its medical applications.
Although no one knows exactly how Wnt
works, other studies have suggested that the signals may cause
cells around an injury to revert to a state similar to that of stem
cells, allowing them to be
reprogrammed to grow back the missing part.
The Lasker Foundation honored John Gurdon (top right) and Shinya Yamanaka (bottom right) for
work on
cell reprogramming and Brian Druker (top left), Nicholas Lydon (bottom left), and Charles
Instead the team is
working with induced pluripotent stem
cells,
cells that have been
reprogrammed to behave like embryonic stem
cells, but can be made from a small sample of the intended recipient's own skin.
In 2006, Yamanaka took Gurdon's
work to the next level by
reprogramming adult mouse skin
cells into induced pluripotent stem
cells.
A better understand of the mechanism by which somatic
cells are
reprogrammed into pluripotent
cells is critical to ongoing
work to understand and to treat disease.
In their most recent
work they report the preparation of
reprogrammed (re --RRB- iNKT
cells.
This
work is an extension of a 2012 paper in the journal
Cell, where Cooke showed that the viruses used to deliver the
reprogramming genes were more than just vehicles.
«Our earlier
work was the first to clearly show in vivo (in a living animal) that mature astrocytes can be
reprogrammed to become functional neurons without the need of
cell transplantation.
«
Work in other organs has shown that
reprogramming cells is rarely accomplished by manipulating a single factor,» Zuo said.
The
work recently received a $ 1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the
cells reprogram, and to employ the
cells for treating the Parkinson's - like symptoms in a mouse model of hypomyelinating disease.
His
work has focused on discovering and characterizing novel small molecules that can control various
cell fates and functions, including stem
cell maintenance, activation, differentiation and
reprogramming in various developmental stages and tissues.
Our
work focuses on discovering and characterizing novel small molecules that can control
cell fate and function in numerous
cell types, including stem
cell maintenance, activation, differentiation, and
reprogramming in various developmental stages and tissues.
Scientists can now
reprogram human skin
cells to make
working cells that resemble «medium spiny neurons», the type of brain
cell that is most affected early in Huntington's disease.
Using this approach, immune
cells are taken from a patient's bloodstream,
reprogrammed to recognize and attack a specific protein found in cancer
cells, then reintroduced into the patient's system, where they get to
work destroying targeted tumor
cells.
Taking this
work a step further, in 2008, they were the first to show that skin
cells could be
reprogrammed into stem
cells (becoming induced pluripotent stem
cells, or iPS
cells), then differentiated into specific dopamine neurons.
Clarke notes that this kind of
work —
reprogramming normal
cells to replace damaged tissues or organs in regenerative medicine, or even growing
cells from an individual's cancer to determine what the best treatment is — speaks to the doctrine rather than challenges it.
This classic
work has inspired several generations of scientists to discover mechanisms of
cell identity, which have informed a lot of the discoveries in stem
cell biology and
reprogramming that have followed.
Dr. Ding's
work builds on the
cell -
reprogramming work of Gladstone Investigator Shinya Yamanaka, MD, PhD.
«The idea of
reprogramming a
cell from your body to become anything your body needs is very exciting,» said Longaker, who emphasized that the
work involved not just a collaboration between his lab and Wu's, but also between the two Stanford institutes.
Dr. Ding's
work revolves around chemical
reprogramming — the use of small molecule drug mixtures to coax fibroblasts into becoming a variety of other
cell types.
Yamanaka's initial
work in
reprogramming cells utilized mice, not human, embryonic stem
cells, and he used the same method for human iPSC production.
Also, rather than using such compounds to
reprogram cells all the way back to the pluripotent state, we are also
working on more direct ways to change one type of
cell directly into another.
However, there is still much
work to be done to prove that the
cells are safe particularly since even this newer method still uses retroviruses to tranfer the
reprogramming factors.»
The
work by Zhang and other researchers could potentially address those problems, since insulin - producing
cells could be made from diabetic patients» own
reprogrammed cells.
«As both a physician and a scientist, Dr. Takahashi embodies the ideal recipient because her
work brings cellular
reprogramming to patients,» says Gladstone president R. Sanders Williams, MD. «Mr. Ogawa's visionary support of translational stem
cell research will help encourage and accelerate the progression of the field.»
This research builds on the groundbreaking
cell -
reprogramming work of another Gladstone scientist and UCSF professor of anatomy, Shinya Yamanaka, MD, PhD.
The University of Minnesota is setting up technology to
work with the
reprogrammed cells, said Jonathan Slack, director of the University's Stem
Cell Institute.
The discovery of
cell reprogramming by Shinya Yamanaka changed the way scientists see
cell biology, but the details of how it
works are still being defined.
Gladstone scientists study how human skin
cells can be
reprogrammed into induced pluripotent stem (iPS)
cells, and they are
working to refine the production of these
cells.
All previous
work on cellular
reprogramming required adding external genes to the
cells, making this accomplishment an unprecedented feat.
The choice of the somatic
cell for
reprogramming, the
reprogramming technology chosen, and the differentiation techniques utilised, all
work synergistically towards the production of mature iPSCs - derived chondrocytes which are comparable to patient - derived chondrocytes, in line with Good Manufacturing Practice guidelines for an «off - the - shelf» stem
cell product.
Exactly how
reprogrammed cells should be deployed clinically still needs to be
worked out.
Dr. Ding's
work builds on the
cell -
reprogramming work of another Gladstone scientist, Senior Investigator Shinya Yamanaka, MD, PhD.